Evolus (EOLS) Net Margin (2019 - 2026)

Evolus (EOLS) posted Net Margin of 14.59% for Q1 2026, down 10237.58% on a QoQ basis from 0.14% in Q4 2025, and up 1298.0% year-over-year from 1.04% in Q1 2025.

Evolus (EOLS) Net Margin (2019 - 2026) Analysis & Trends

Evolus' Net Margin history runs 8 years deep, the most recent figure standing at 14.59% for Q1 2026.

  • Quarterly Net Margin rose 1298.0% year-over-year to 14.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 14.39% (up 601.0% YoY) and the FY2025 annual result came in at 17.38%, up 156.0% from the prior year.
  • Net Margin was 14.59% for Q1 2026 at Evolus, down from 0.14% in the prior quarter.
  • Across five years, Net Margin topped out at 0.14% in Q4 2025 and bottomed at 63.16% in Q2 2022.
  • A 5-year average of 29.34% and a median of 27.57% in 2025 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin plunged 10390 bps — and 2023, when it surged 2640 bps.
  • Evolus' Net Margin stood at 30.16% in 2022, then surged by 36 bps to 19.4% in 2023, then surged by 56 bps to 8.6% in 2024, then surged by 102 bps to 0.14% in 2025, then slumped by 10238 bps to 14.59% in 2026.
  • Business Quant data shows EOLS's Net Margin at 14.59% in Q1 2026, 0.14% in Q4 2025, and 22.82% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Evolus 390.47 Mn 340.68 Mn 48.90 Mn -14.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.59%
Dec 31, 2025 0.14%
Sep 30, 2025 -22.82%
Jun 30, 2025 -24.70%
Mar 31, 2025 -27.57%
Dec 31, 2024 -8.60%
Sep 30, 2024 -31.38%
Jun 30, 2024 -16.96%
Mar 31, 2024 -22.09%
Dec 31, 2023 -19.40%
Sep 30, 2023 -33.83%
Jun 30, 2023 -36.76%
Mar 31, 2023 -35.45%
Dec 31, 2022 -30.16%
Sep 30, 2022 -59.81%
Jun 30, 2022 -63.16%
Mar 31, 2022 -51.61%
Dec 31, 2021 -52.45%
Sep 30, 2021 -72.85%
Jun 30, 2021 -59.78%